Neuronetics Balance Sheet Health
Financial Health criteria checks 5/6
Neuronetics has a total shareholder equity of $34.2M and total debt of $59.3M, which brings its debt-to-equity ratio to 173.4%. Its total assets and total liabilities are $115.8M and $81.6M respectively.
Key information
173.4%
Debt to equity ratio
US$59.28m
Debt
Interest coverage ratio | n/a |
Cash | US$59.68m |
Equity | US$34.19m |
Total liabilities | US$81.64m |
Total assets | US$115.83m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NRC's short term assets ($93.8M) exceed its short term liabilities ($19.8M).
Long Term Liabilities: NRC's short term assets ($93.8M) exceed its long term liabilities ($61.8M).
Debt to Equity History and Analysis
Debt Level: NRC has more cash than its total debt.
Reducing Debt: NRC's debt to equity ratio has increased from 42.8% to 173.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NRC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NRC has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 12.2% each year.